Keurig Dr Pepper, the Consumer Defensive sector company, was revisited by a Wall Street analyst today. Analyst Robert Moskow from TD Cowen maintained a Hold rating on the stock and has a $31.00 price target.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Robert Moskow has given his Hold rating due to a combination of factors that balance solid near-term execution with unresolved strategic and margin risks. Keurig Dr Pepper exceeded first-quarter expectations and indicated that the year is tracking slightly better than initially planned, but the company also lowered its outlook for the second quarter to reflect ongoing pressure from elevated coffee input costs and inventory normalization in pods and brewers.
Moskow also believes the stock’s upside is limited until investors gain greater clarity on the integration of the JDEP coffee assets and the planned separation of the Beverage and Global Coffee operations, which has now been pushed out to early 2027. While the U.S. Refreshment Beverages segment continues to deliver strong, innovation-led growth and profit expansion, this strength is partially offset by weak coffee performance and compressed gross margins, keeping the risk/reward profile balanced rather than compelling for a more aggressive rating.
In another report released yesterday, Barclays also maintained a Hold rating on the stock with a $28.00 price target.